These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 14004979)
1. [Clinical and biological efficacy of a spirolactone in the treatment of various water-salt retentions]. WAREMBOURG H; LINQUETTE M; LEKIEFFRE J; FOSSATI P Lille Med; 1961; 6():668-71. PubMed ID: 14004979 [No Abstract] [Full Text] [Related]
2. [Initial results in the spirolactone treatment of 2 cases of the edematous syndrome with secondary aldosteronism]. DULAC JF; OUGIER J; DOURY P; BEN-ZENOU A; WEIL B Bull Mens Soc Med Mil Fr; 1960 Dec; 54():332-5. PubMed ID: 13724900 [No Abstract] [Full Text] [Related]
3. [Diuretic properties of a spirolactone]. SCHWARTZ J; BLOCH R Strasb Med; 1961 Feb; 12():103-13. PubMed ID: 13749099 [No Abstract] [Full Text] [Related]
4. The 45-year story of the development of an anti-aldosterone more specific than spironolactone. Ménard J Mol Cell Endocrinol; 2004 Mar; 217(1-2):45-52. PubMed ID: 15134800 [TBL] [Abstract][Full Text] [Related]
5. Interactions of high salt intake and the response of the cardiovascular system to aldosterone. Conlin PR Cardiol Rev; 2005; 13(3):118-24. PubMed ID: 15831143 [TBL] [Abstract][Full Text] [Related]
6. Drospirenone and its antialdosterone properties. Genazzani AR; Mannella P; Simoncini T Climacteric; 2007 Feb; 10 Suppl 1():11-8. PubMed ID: 17364593 [TBL] [Abstract][Full Text] [Related]
7. [Aldosterone blockade in essential hypertension]. Venco A; Grandi AM Ital Heart J; 2005 May; 6 Suppl 1():34S-42S. PubMed ID: 15945298 [TBL] [Abstract][Full Text] [Related]
8. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties. Rübig A Climacteric; 2003 Oct; 6 Suppl 3():49-54. PubMed ID: 15018248 [TBL] [Abstract][Full Text] [Related]
9. Aldosterone and cardiovascular pathology: from bench to bedside. Vintilă M; Băluţă M Rom J Intern Med; 2004; 42(1):15-26. PubMed ID: 15529592 [TBL] [Abstract][Full Text] [Related]
10. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension. Gaddam KK; Pratt-Ubunama MN; Calhoun DA Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096 [TBL] [Abstract][Full Text] [Related]
11. [Aldosterone and kidney damage: clinical implications]. Del Vecchio L; Sitia S G Ital Nefrol; 2009; 26(3):347-54. PubMed ID: 19554532 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of different progestogens: the special case of drospirenone. Sitruk-Ware R Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade. Del Vecchio L; Procaccio M; Viganò S; Cusi D Nat Clin Pract Nephrol; 2007 Jan; 3(1):42-9. PubMed ID: 17183261 [TBL] [Abstract][Full Text] [Related]